Cellular fibronectin expression in chronic hepatitis C virus patients

Area of Science:

• Hepatology
• Molecular Biology
• Biochemistry

Background:

• Hepatitis C virus (HCV) infection is a leading cause of liver fibrosis, cirrhosis, and hepatocellular carcinoma.
• Fibronectin, a key protein in tissue remodeling, is upregulated during liver injury.
• Assessing liver fibrosis severity non-invasively is crucial for managing chronic HCV.

Purpose of the Study:

• To investigate the correlation between cellular fibronectin expression in peripheral blood fibrocytes and the severity of liver fibrosis in chronic HCV patients.
• To evaluate cellular fibronectin RNA as a potential biomarker for liver fibrosis staging in HCV.

Main Methods:

• Analysis of cellular fibronectin RNA expression in peripheral blood fibrocytes from 20 HCV fibrotic patients, 10 HCV cirrhotic patients, and 10 controls using PCR.
• Correlation of fibronectin levels with liver biopsy Metavir scores, APRI, and FIB-4 scores.

Main Results:

• Cellular fibronectin RNA levels were significantly higher in fibrotic HCV livers compared to cirrhotic HCV livers (p=0.019).
• No cellular fibronectin expression was detected in control subjects.
• A significant correlation was observed between cellular fibronectin RNA and Metavir, APRI, and FIB-4 scores, but diagnostic performance was lower than APRI and FIB-4.

Conclusions:

• Cellular fibronectin RNA demonstrates good reproducibility and can differentiate between HCV-related liver fibrosis (F1-F3), cirrhosis (F4), and normal liver (F0).
• While not superior to existing scores, fibronectin may serve as a complementary biomarker in HCV liver disease assessment.